FDAImports.com has opened an office in Chennai, India, a major commercial and economic hub located in Tamil Nadu, India. India, with significant exports of rice, wheat, sugar, seafood and other FDA-regulated products, is a major trade partner with the United States for a variety of key commodities. In fact, India is currently leading the world in rice trade, surpassing Thailand as a 4-year ban on non-basmati rice exports comes to an end.1 “Indian companies export some of the world’s finest products to the United States,” said Rick Quinn, Principal at FDAImports.com and head of the Chennai, India office, “including medical devices, laser products, bulk and finished drugs, seafood, conventional foods and dietary supplements.”
The U.S. Food and Drug Administration maintains two offices in India (New Delhi and Mumbai), the only country besides China to have more than one FDA post. “FDA is paying attention to India like never before,” said Quinn. “FDA’s enforcement activity will undoubtedly increase as the regulations implementing the Food Safety Modernization Act take effect. A key offering for the new FDAImports.com India office will be to continue to assist Indian companies with expediting FDA clearance of imported goods and also obtaining removal from FDA’s Detention Without Physical Examination (“Import Alert”) regime.”
“While ‘prevention is the best medicine,’ often firms don’t appreciate the magnitude of the regulatory risks or obligations until a problem arises. And that’s when our teams can jump into action quickly to get product cleared and moving. Having an India-based office with local native speakers who are also qualified experts will assist our clients exponentially.” Quinn stated.
Click for more information the Chennai, India office of FDAImports.com
Sources:
1. www.fas.usda.gov/psdonline/circulars/grain.pdf
